CSIMarket
 


Opko Health Inc   (OPK)
Other Ticker:  
 

Opko Health Inc 's Leverage Ratio

OPK's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -1.83%, in III Quarter 2023 ,Leverage Ratio deteriorated to 0.42, below the Opko Health Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 231 other companies have achieved lower Leverage Ratio than Opko Health Inc in the III Quarter 2023. While Leverage Ratio total ranking has improved so far in the third quarter 2023 to 905, from total ranking in the second quarter 2023 at 943 .

Explain Leverage Ratio?
Who are OPK Customers?
What are OPK´s Total Liabilities?


OPK Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -11.33 % -10.67 % -3.91 % -7.33 % -7.73 %
Y / Y Total Liabilities Change 2.75 % -4.19 % -10.71 % -15.25 % -8.64 %
Leverage Ratio MRQ 0.42 0.41 0.4 0.39 0.37
OPK's Total Ranking # 905 # 943 # 859 # 956 # 622
Seq. Equity Change -5.91 % -1.06 % -0.63 % -4.14 % -5.22 %
Seq. Total Liabilities Change -1.83 % 0.92 % 2.02 % 1.66 % -8.46 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 232
Healthcare Sector # 411
Overall Market # 905


Leverage Ratio Statistics
High Average Low
1.05 0.45 0.23
(Jun 30 2013)   (Mar 31 2017)




Financial Statements
Opko Health Inc 's Equity $ 1,445 Millions Visit OPK's Balance sheet
Opko Health Inc 's Total Liabilities $ 612 Millions Visit OPK's Balance sheet
Source of OPK's Sales Visit OPK's Sales by Geography


Cumulative Opko Health Inc 's Leverage Ratio

OPK's Leverage Ratio for the trailling 12 Months

OPK Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -11.33 % -10.67 % -3.91 % -7.33 % -7.73 %
Y / Y Total Liabilities TTM Growth 2.75 % -4.19 % -10.71 % -15.25 % -8.64 %
Leverage Ratio TTM 0.4 0.39 0.38 0.39 0.4
Total Ranking TTM # 856 # 4 # 5 # 5 # 850
Seq. Equity TTM Growth -5.91 % -1.06 % -0.63 % -4.14 % -5.22 %
Seq. Total Liabilities TTM Growth -1.83 % 0.92 % 2.02 % 1.66 % -8.46 %


On the trailing twelve months basis Despite of the repayements of liabilities of -1.83% in the trailing twelve months ending in III Quarter 2023, Leverage Ratio improved to 0.4, below Opko Health Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 218, during the past 12 months, other companies have achieved lower Leverage Ratio than Opko Health Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 4 to 856.

Explain Leverage Ratio?
Who are OPK Customers?
What are OPK´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 219
Healthcare Sector # 403
Within the Market # 856


trailing twelve months Leverage Ratio Statistics
High Average Low
0.71 0.44 0.31
(Dec. 30, 2013)   (Sep 30 2017)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Perrigo Company Plc  1.16 $ 5,514.500  Millions$ 4,738.100  Millions
Novartis Ag  1.14 $ 53,195.000  Millions$ 46,750.000  Millions
Enanta Pharmaceuticals Inc  1.13 $ 245.540  Millions$ 216.735  Millions
Scpharmaceuticals Inc   1.13 $ 55.404  Millions$ 49.146  Millions
Eyenovia inc   1.12 $ 17.645  Millions$ 15.780  Millions
Johnson and Johnson  1.11 $ 79,025.000  Millions$ 71,228.000  Millions
2seventy Bio Inc   1.09 $ 334.384  Millions$ 306.422  Millions
Ani Pharmaceuticals Inc  1.07 $ 460.053  Millions$ 429.861  Millions
Zevra Therapeutics Inc   1.06 $ 71.512  Millions$ 67.470  Millions
Neubase Therapeutics inc   1.04 $ 9.485  Millions$ 9.137  Millions
Actinium Pharmaceuticals Inc   1.03 $ 44.839  Millions$ 43.583  Millions
Nighthawk Biosciences inc   1.01 $ 33.623  Millions$ 33.447  Millions
Virpax Pharmaceuticals Inc   1.00 $ 6.533  Millions$ 6.506  Millions
Royalty Pharma Plc  1.00 $ 9,614.891  Millions$ 9,585.097  Millions
Avalo Therapeutics Inc   0.99 $ 14.575  Millions$ 14.695  Millions
Bio path Holdings inc   0.99 $ 2.496  Millions$ 2.525  Millions
Lexicon Pharmaceuticals Inc   0.98 $ 136.969  Millions$ 139.510  Millions
Gri Bio Inc   0.98 $ 2.177  Millions$ 2.227  Millions
Assertio Holdings inc   0.97 $ 187.155  Millions$ 192.873  Millions
Entrada Therapeutics Inc   0.97 $ 238.370  Millions$ 246.663  Millions
Tg Therapeutics Inc   0.95 $ 156.776  Millions$ 164.769  Millions
Pieris Pharmaceuticals Inc   0.95 $ 28.866  Millions$ 30.510  Millions
Spero Therapeutics Inc   0.92 $ 49.276  Millions$ 53.705  Millions
Unity Biotechnology Inc   0.91 $ 33.064  Millions$ 36.206  Millions
Kiora Pharmaceuticals Inc  0.87 $ 7.085  Millions$ 8.104  Millions
Igm Biosciences Inc   0.87 $ 220.488  Millions$ 253.862  Millions
Eton Pharmaceuticals Inc   0.87 $ 14.634  Millions$ 16.892  Millions
Verastem inc   0.86 $ 71.814  Millions$ 83.180  Millions
Onconova Therapeutics inc   0.86 $ 12.521  Millions$ 14.517  Millions
Cryoport inc   0.86 $ 463.128  Millions$ 537.528  Millions

Date modified: 2023-11-07T12:17:11+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com